Xcout Intel
Nivagen Pharmaceuticals, Inc.
Nivagen Pharmaceuticals, Inc. is a U.S.-based pharmaceutical company that develops, manufactures, and markets generic and specialty prescription medicines, including oral and injectable products. It serves healthcare providers, hospitals, pharmacies, and patients in the United States.
Subscribe to see Nivagen Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nivagen Pharmaceuticals, Inc. at a glance
Nivagen Pharmaceuticals, Inc. is a pharmaceuticals company headquartered in United States. It has raised at least $31M across the 3 funding rounds on record. Its most recent funding round raised $5M in September 2023. Xcout tracks 8 named people at Nivagen Pharmaceuticals, Inc., including Jay Shukla (President & CEO). Xcout recorded 26 job postings from Nivagen Pharmaceuticals, Inc. in the last 90 days.
Nivagen Pharmaceuticals, Inc. leadership
- Jay ShuklaPresident & CEO
- Robert MillerChief Financial Officer
- Dr. Dasaradhi LakkarajuChief Science Officer
- Dr. Nirav PatelVice President, Research & Development
- Venkatesh MuttepwarVice President – Projects
- Jay RoderickHead of Manufacturing, Sterile Operations
2 more named people on record for Nivagen Pharmaceuticals, Inc., with roles, board committees and tenure — see the full roster →
Nivagen Pharmaceuticals, Inc. funding rounds
At least $31M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $5M | — | |
| SEC Form D filing | $16M | — | |
| SEC Form D filing | $10M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Nivagen Pharmaceuticals, Inc.
Xcout recorded 26 job postings from Nivagen Pharmaceuticals, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Nivagen Pharmaceuticals, Inc.'s hiring signals →
Recent Nivagen Pharmaceuticals, Inc. news
Nivagen Pharmaceuticals, Inc. competitors
A few of Nivagen Pharmaceuticals, Inc.'s closest competitors — see the full list of competitors and alternatives →
Founded in 2003, Nexus Pharmaceuticals is a US-based, family-owned, and minority-led pharmaceutical manufacturer that specializes in innovative processes to produce difficult-to-manufacture injectable drugs.
Exela Pharma Sciences is a specialty pharmaceutical company that develops and manufactures proprietary and generic sterile injectable products, including liquid vials, IV bags, lyophilized vials, and pre-filled syringes. The company serves healthcare providers and patients by addressing drug shortages and also operates as a contract development and manufacturing organization (CDMO) providing cGMP manufacturing and research services.
American Regent, Inc. is a pharmaceutical and healthcare company headquartered in Shirley, New York. The company manufactures and supplies injectable medications and supports patient health as a guiding principle.
Auven Therapeutics is a privately held specialty pharmaceutical company focused on acquiring, developing, and commercializing late-stage and specialty medicines. It serves patients and healthcare providers through pharmaceutical products developed with industry and clinical partners.
Azurity Pharmaceuticals is a U.S.-based specialty pharmaceutical company that develops and commercializes medicines for underserved patient populations, including treatments for rare diseases and complex conditions. It focuses on patient-friendly dosage forms and serves healthcare providers, patients, and caregivers, including pediatric and other populations with unmet medication needs.
Milla Pharmaceuticals Inc. is the U.S. subsidiary of the Belgian pharmaceutical group A.forall, specializing in the commercialization and distribution of FDA-approved injectable medications. The company serves wholesalers, distributors, hospitals, and infusion care clinics across the United States to provide access to affordable generic and institutional pharmaceutical products.
Get Nivagen Pharmaceuticals, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Nivagen Pharmaceuticals, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nivagen Pharmaceuticals, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access